The World Health Organization (WHO) on Friday warned against the use of anti-viral drug remodecivir in various hospitals against coronavirus patients. The WHO says there has been no evidence of coronary disease patients with mild or severe symptoms from Remodesvir.

Recent guidelines have found no evidence of recurrence, suggesting that the drug may have reduced mortality or that patients may require mechanical ventilation after its use. Remadecivir was originally created for the Ebola virus, but the drug has not been successful.

Subsequently, the corona virus also began to use ten drug kits on patients. Some experiments resulted in better results. Because of this, ಷ ಷ ಷಧ ರಿ ರಿ ಮಾಧಮಾಮಾಾಸಾಸವಿರ್ರ್ರ್ rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema rema Currently it is only used in emergency situations in India and is not fully approved.

A WHO inquiry last month found that drug abuse had little or no effect on corona patients. WHO’s latest guidelines are a big setback for ce cialis. The WHO’s Guideline Development Group (GDG) committee has based its recommendation on evidence review, which includes data on more than 7,000 patients.

ALSO READ: Reduced risk of death of corona patients by 62% with RemedySaver: Study